医用大麻市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPRE00015806
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Medical Cannabis Market Opportunities and Forecast by 2031

Buy Now

预计医用大麻市场规模将从 2023 年的 165.6 亿美元增至 2031 年的 972 亿美元。预计 2023-2031 年期间,该市场的复合年增长率将达到 28.8%。生活方式的改变可能仍将是市场的主要趋势。CAGR of 28.8% during 2023–2031. Lifestyle changes will likely remain a key trend in the market.

医用大麻市场分析

医用大麻产品获批数量不断增加、发展中国家对大麻药用用途的接受度不断提高、对大麻药用用途的研究不断增加以及政府对传播大麻意识和探索大麻药用价值的资金不断增加是市场发展的关键驱动因素。此外,COVID-19 期间对大麻的需求不断增长,这对医用大麻市场参与者来说是一个关键机会。

医用大麻市场概况

大麻的药用潜力吸引了众多研究人员和公司将大麻用于医疗应用。例如,四氢大麻酚 (THC) 主要用于生产药品。美国食品药品管理局 (FDA) 已批准使用 THC 为基础的药品,如那比隆 (Cesamet) 和屈大麻酚 (Marinol),用于治疗化疗患者的恶心;这些药物还用于刺激患有消瘦综合征(艾滋病的一种症状)患者的食欲。同样,各种基于大麻的产品已获批准或正在进行临床试验。例如,那比西莫 (Sativex) 是一种已获批准的药物,已在加拿大、英国和一些欧洲国家商业化。那比西莫是一种大麻提取物,用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合而成。 2020 年 2 月,加拿大公司 CanaQuest Medical Corp 向加拿大卫生部申请生产和商业化 Mentabinol。Mentabinol 是一种基于 THC 的产品,其批准申请已根据《大麻法》提交。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医用大麻市场:

医用大麻市场
  • Medical Cannabis Market
    复合年增长率(2023 - 2031)
    28.8%
  • 2023 年市场规模
    165.6 亿美元
  • 2031年市场规模
    972亿美元

市场动态

增长动力
  • 医用大麻审批数量的增加和公司业务的扩张正在推动全球医用大麻市场的增长
未来趋势
  • 预计分销量的增加将吸引更多的投资,并可能在预测期内推动市场增长。
机会
  • 控制 COVID-19 疫情的呼声日益高涨,推动了对医用大麻的需求,从而为医用大麻市场参与者提供了机会。

关键人物

  • Aphria 公司
  • 极光大麻
  • 大麻科学公司
  • Canopy Growth 公司
  • 医用大麻公司
  • VIVO 大麻公司
  • 拯救世界
  • 蒂尔雷
  • 克罗诺斯集团
  • 坎沃里

区域概况

Medical Cannabis Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Medical Cannabis Market产品类型
  • 花朵
  • 浓缩物
  • 平板电脑
  • 大麻油和外用药膏
  • 胶囊
  • 饮料和食品
Medical Cannabis Market医疗应用
  • 疼痛管理
  • 神经健康管理
  • 心理健康管理
Medical Cannabis Market化合物
  • 四氢大麻酚 [THC]-占主导地位
  • 大麻二酚 [CBD]-显性
  • 平衡 THC 和 CBD
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

医用大麻市场驱动因素和机遇

大麻药用研究日益增多

随着许多欧洲国家将大麻合法化,大麻生产商越来越重视找到快速准确的方法来测定其产品的质量和效力。大麻的使用推动了对高效大麻测试流程的需求,这也推动了该地区的研究活动。欧盟议会旨在提出一项基于资金充足的科学研究的欧盟范围的医用大麻政策;欧洲议会议员于 2019 年 2 月就大麻的药用用途作出了决议,主要目的是明确区分这些植物的药用和其他用途。然而,没有一个欧盟国家授权吸食或在家中种植大麻用于医疗目的。与此同时,世卫组织已正式建议拒绝将 CBD 归类为管制物质。然而,欧盟并没有针对该地区大麻的医疗或娱乐用途的通用规则。大麻或大麻素有助于刺激食欲并缓解癫痫、哮喘、癌症和阿尔茨海默氏症等精神障碍;然而,这些领域还需要更多的研究。欧洲议会的主要目标是解决该地区医用大麻的研究空白,并促进其成员国发挥大麻药物的潜力。

COVID-19 期间大麻需求不断增长

根据 Worldometer 数据,截至 2021 年 4 月 15 日,全球 COVID-19 病例数已达到约 1.38 亿,死亡人数达 290 万。研究人员正在探索多种可能的治疗方案,包括现有药物。研究人员正在研究多种可能的治疗方案,包括现有药物。他们发现医用大麻可用于治疗 COVID-19。据 HEALTH EUROPA 的医用大麻网络报道,“迈阿密大学的研究人员将进行一项匿名调查,以了解医用大麻患者的心理健康和身体健康状况,并根据 COVID-19 相关的关闭和更新情况,检查患者使用大麻的频率、剂量和给药途径的变化。”此外,根据欧洲毒品和毒瘾监测中心 (EMCDDA) 于 2020 年 5 月发表的一篇文章,专门销售大麻产品的市场 Cannazon 在 2020 年 1 月至 2020 年 3 月期间销售了价值约 483 万美元(430 万欧元)的大麻,按数量计算,相当于 1.6 公吨大麻。因此,控制 COVID-19 疫情的迫切需求正在推动对医用大麻的需求,从而为医用大麻市场参与者提供机会。

医用大麻市场报告细分分析

有助于得出医用大麻市场分析的关键部分是类型、交付和应用。

  • 根据产品类型,医用大麻市场分为花、浓缩物、片剂、大麻油和外用药膏、胶囊以及饮料和食品。2023 年,花类产品占据了最大的市场份额。
  • 根据医疗应用,医用大麻市场细分为疼痛管理、神经健康管理、心理健康管理等。疼痛管理领域在 2023 年占据了最大的市场份额。
  • 根据医用化合物,医用大麻市场分为四氢大麻酚 (THC) 占主导地位、大麻二酚 (CBD) 占主导地位以及平衡的 THC 和 CBD。四氢大麻酚 (THC) 占主导地位的细分市场在 2023 年占据了最大的市场份额。

医用大麻市场份额按地区分析

医用大麻市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

在北美,美国医用大麻市场占有该地区最大的份额。美国是北美地区医用大麻市场规模最大、增长最快的国家。由于大麻产品的合法化和吸引力,美国在医用大麻市场上占据主导地位。该市场的增长主要得益于公众对医用大麻的认识、越来越多的研究和合作以探索创新的治疗应用,此外,医用大麻的合法化以及公共和私人意识计划将推动市场的增长。例如,美国 36 个州已将医用大麻合法化用于医疗用途。

 根据美国癌症协会最近对大麻的研究,对对阿片类药物有抗药性的晚期癌症患者的研究发现,与安慰剂相比,接受低剂量和中剂量大麻的患者报告镇痛效果有所改善,并且实验表明有助于缓解患者的慢性疼痛。根据大麻贸易经济学,美国合法大麻产业的增长在 2019 年价值 136 亿美元,创造了近 34 万个与处理植物相关的工作岗位。

医用大麻市场报告范围

报告属性细节
2023 年的市场规模165.6亿美元
2031 年市场规模972亿美元
全球复合年增长率(2023 - 2031)28.8%
史料2021-2022
预测期2024-2031
涵盖的领域按产品类型
  • 花朵
  • 浓缩物
  • 平板电脑
  • 大麻油和外用药膏
  • 胶囊
  • 饮料和食品
按医疗应用
  • 疼痛管理
  • 神经健康管理
  • 心理健康管理
按化合物
  • 四氢大麻酚 [THC]-占主导地位
  • 大麻二酚 [CBD]-显性
  • 平衡 THC 和 CBD
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Aphria 公司
  • 极光大麻
  • 大麻科学公司
  • Canopy Growth 公司
  • 医用大麻公司
  • VIVO 大麻公司
  • 拯救世界
  • 蒂尔雷
  • 克罗诺斯集团
  • 坎沃里
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

医用大麻市场新闻和最新发展

医用大麻市场通过收集主要和次要研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了医用大麻市场的一些发展情况:

  • Tilray Medical 是 Tilray Brands, Inc.(简称“Tilray Brands”)(纳斯达克股票代码:TLRY 和多伦多证券交易所代码:TLRY)的一个部门,也是医用大麻领域的全球领导者,它使患者和医疗保健从业者之间的治疗联盟能够做出明智的个性化健康决策,从而改变医疗保健。该公司今天宣布在澳大利亚推出 Broken Coast EU-GMP 认证的医用大麻产品。(来源:Tilray Medical,公司网站,2024 年 6 月)

医用大麻市场报告覆盖范围和交付成果

“医用大麻市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 范围内涵盖的所有主要细分市场的全球、区域和国家层面的肠外营养市场规模和预测
  • 肠外营养市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 肠外营养市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及医用大麻市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the medical cannabis market?

The market is expected to register a CAGR of 28.8% during 2023–2031.

What are the future trends of the medical cannabis market?

Widespread Distribution of Medical Cannabis will likely remain a key trend in the market.

Which are the leading players operating in the medical cannabis market?

Aphria, Inc., Aurora Cannabis, Cannabis Science, Inc, Canopy Growth Corporation, Medical Marijuana, Inc., VIVO Cannabis Inc, Tikun Olam, Tilray, The Cronos Group, Canvory.

What are the driving factors impacting the carboxy therapy market?

Key factors driving the growth of the market are increasing number of approvals for medical cannabis products, rising acceptance for medicinal use of Cannabis in developing countries, growing research on medicinal use of Cannabis, and escalating government funding for spreading awareness and exploring medicinal benefits of Cannabis.

Which region dominated the medical cannabis market in 2023?

North America dominated the medical cannabis market in 2023

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..